Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amifostine with High-Dose PEB in Childhood Germ Cell Tumors
NCT00003811Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Apr 2000
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, open-label, single-arm trial of amifostine in malignant germ cell tumor (MGCT), sponsored by Children's Oncology Group. Primary endpoint: Feasibility from Efficacy Standpoint. Started Apr 2000; status: completed.
02
Drugs
amifostine
03
Conditions
malignant germ cell tumor (MGCT)
Beyond the preview
Go deeper on NCT00003811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003811.